Generation and Characterization of Anti-phenyl Sulfate Monoclonal Antibodies and a Potential Use for Phenyl Sulfate Analysis in Human Blood-Reference-Cited by-同舟云学术

Generation and Characterization of Anti-phenyl Sulfate Monoclonal Antibodies and a Potential Use for Phenyl Sulfate Analysis in Human Blood

Published:2018-08-01 Issue:8 Volume:41 Page:1170-1177
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Kanemitsu Yoshitomi¹,Tsukamoto Hiroki¹,Matsumoto Yotaro¹,Nozawa-Kumada Kanako²,Kondo Yoshinori²,Abe Takaaki³⁴,Tomioka Yoshihisa¹

Affiliation:

1. Laboratory of Oncology, Pharmacy Practice and Sciences, Graduate School of Pharmaceutical Sciences, Tohoku University

2. Laboratory of Molecular Transformation, Graduate School of Pharmaceutical Sciences, Tohoku University

3. Department of Medical Science, Graduate School of Biomedical Engineering, Tohoku University

4. Department of Clinical Biology and Hormonal Regulation, Graduate School of Medicine, Tohoku University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/41/8/41_b17-00925/_pdf

Reference28 articles.

1. 1) Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt K-U, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G. Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes. Kidney Int., 72, 247–259 (2007).

2. 2) Jha V, Wang AYM, Wang H. The impact of CKD identification in large countries: the burden of illness. Nephrol. Dial. Transplant., 27 (Suppl. 3), 32–38 (2012).

3. 3) Levin A, Stevens PE. Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int., 85, 49–61 (2014).

4. 4) Wouters OJ, O’Donoghue DJ, Ritchie J, Kanavos PG, Narva AS. Early chronic kidney disease: diagnosis, management and models of care. Nat. Rev. Nephrol., 11, 491–502 (2015).

5. 5) James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet, 375, 1296–1309 (2010).